[New bisphosphonates and trends in drug therapy for osteoporosis: preface].
Matsumoto
Toshio
T
D019386:Alendronate; D050071:Bone Density Conservation Agents / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D004164:Diphosphonates / Q000008:administration & dosage; D012968:Etidronic Acid / Q000031:analogs & derivatives; D019317:Evidence-Based Medicine; D006801:Humans; D007093:Imidazoles; D010024:Osteoporosis / Q000188:drug therapy*; D000068296:Risedronic Acid; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; C087958:YM 529; D000077211:Zoledronic Acid; D000068296:Risedronic Acid; D012968:Etidronic Acid; D019386:Alendronate